Tech Company Financing Transactions

PharmAthene Funding Round

On 10/12/2004, PharmAthene landed $50 million in Series B funding from Bear Stearns Health Innoventures, MPM Capital and HealthCare Ventures.

Transaction Overview

Company Name
PharmAthene
Announced On
10/12/2004
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors

Bear Stearns Health Innoventures (Lead Investor) (Elizabeth Czerepak)

MPM Capital (Lead Investor) (Ansbert Gadicke)

HealthCare Ventures (James Cavanaugh)

Proceeds Purpose
This Series B Financing will enable PharmAthene to become a leader in critical biodefense products beginning with the continued development of ToxBloxTM (a potent inhibitor of anthrax toxin being developed as a treatment for symptomatic patients).

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Park Pl. 450
Annapolis, MD 21401
USA
Phone
(410) 269-2600
Website
www.pharmathene.com
Email Address
[email protected]
Overview
PharmAthene was formed to meet the critical needs of this Nation by developing biodefense products.
Profile
PharmAthene LinkedIn Company Profile
Social Media
PharmAthene Company Twitter Account
Company News
PharmAthene News
Facebook
PharmAthene on Facebook
YouTube
PharmAthene on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Gill
  John Gill LinkedIn Profile  John Gill Twitter Account  John Gill News  John Gill on Facebook
Chief Financial Officer
Philip MacNeill
  Philip MacNeill LinkedIn Profile  Philip MacNeill Twitter Account  Philip MacNeill News  Philip MacNeill on Facebook
VP - Bus. Development
Jeffrey Steinberg
  Jeffrey Steinberg LinkedIn Profile  Jeffrey Steinberg Twitter Account  Jeffrey Steinberg News  Jeffrey Steinberg on Facebook
VP - Product Management
John Troyer
  John Troyer LinkedIn Profile  John Troyer Twitter Account  John Troyer News  John Troyer on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/7/2004: K2 Optronics venture capital transaction
Next: 10/12/2004: Chantry Networks venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

Our team works diligently to report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.